Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Mar;43(3):575-85.
doi: 10.1023/a:1018819326009.

Somatostatin attenuates microcirculatory impairment in acute sodium taurocholate-induced pancreatitis

Affiliations

Somatostatin attenuates microcirculatory impairment in acute sodium taurocholate-induced pancreatitis

T Plusczyk et al. Dig Dis Sci. 1998 Mar.

Abstract

Using in vivo microscopy, red blood cell (RBC) velocities, functional capillary density (FCD), and overall changes in capillary blood flow (PI) were estimated following intraductal infusion of sodium taurocholate (0.8 ml; 4%) alone or in combination with systemic administration of somstostatin (single bolus SMS 100 microg/100 g body wt). Sodium taurocholate mediated a significant transient decrease in RBC velocities and a sustained decrease in FCD, which were paralleled by dramatic flow heterogeneity. Therefore, a significant reduction in overall capillary blood flow was calculated. Additional SMS treatment reduced microcirculatory impairment as expressed by reduction of blood flow heterogeneity, a less rarified functional capillary density, and a recovery of RBC velocities and acinar capillary overall perfusion to control values. As a result of this microcirculatory improvement, pancreas histology revealed slightly less severe tissue damage compared to the non-SMS-treated pancreatitis group. These findings demonstrate that exogenous SMS infusion can improve microcirculatory failure in acute biliary pancreatitis, which should have a beneficial effect on the course of the disease.

PubMed Disclaimer

References

    1. Am J Physiol. 1991 Feb;260(2 Pt 1):G346-51 - PubMed
    1. J Clin Invest. 1986 Oct;78(4):1056-63 - PubMed
    1. Gastroenterology. 1995 Jul;109(1):231-8 - PubMed
    1. Proc Soc Exp Biol Med. 1989 Nov;192(2):182-6 - PubMed
    1. Internist (Berl). 1989 Nov;30(11):705-17 - PubMed